In early July, the Food and Drug Administration (FDA) accepted Boehringer Ingelheim Pharmaceuticals’ new drug application (NDA) for its investigational compound for the treatment of idiopathic pulmonary fibrosis (IPF), nintedanib, and granted priority review designation.
High-resolution computed tomography (HRCT) scans have quickly become the most effective tool for firmly diagnosing idiopathic pulmonary fibrosis (IPF).
A groundbreaking new genetic discovery could lead to future pharmaceutical therapies to treat the rare condition, idiopathic pulmonary fibrosis (IPF).
The Pulmonary Fibrosis Foundation is expanding its Patient Care Network and Patient Registry, which it formed in late 2013 to improve the quality of life for patients with all types of pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF).
Test Excel Embed
If you have type 2 diabetes, your body either does not make enough insulin or makes insulin but does
not know how to use it the right way. If your body cannot use insulin correctly, you may need to take
insulin injections. Here is what you need to know if your healthcare provider has prescribed insulin for you
Our exclusive infographic shows how it's done
A list of the physicians on the American Medical Association Specialty Society Relative Value Scale Update Committee.